Innate Immunity and Intracellular Trafficking: Insights for Novel Anti- HIV-1 Therapeutics

E-ISSN： 1875-6204|3|2|97-117

ISSN： 1570-1603

Source： Current Pharmacogenomics, Vol.3, Iss.2, 2005-06, pp. : 97-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antimicrobial Peptides: Mediators of Innate Immunity as Templates for the Development of Novel Anti-Infective and Immune Therapeutics

Current Pharmaceutical Design, Vol. 10, Iss. 23, 2004-09 ,pp. : 2891-2905

Bentham Science Publishers

Access to resources Recommend Favorite

NHE-1: A Promising Target for Novel Anti-cancer Therapeutics

Current Pharmaceutical Design, Vol. 18, Iss. 10, 2012-04 ,pp. : 1372-1382

Bentham Science Publishers

Access to resources Recommend Favorite

African ancestry and innate immunity contribute to the incidence of multicentric Castleman’s disease in HIV-1/Kaposi’s sarcoma herpesvirus-coinfected individuals

By Westrop Samantha J Lagos Dimitrios Boshoff Chris Bower Mark Imami Nesrina

Future Virology, Vol. 7, Iss. 7, 2012-07 ,pp. : 729-734

Future Medicine

Access to resources Recommend Favorite

TSG101: A Novel Anti-HIV-1 Drug Target

Current Medicinal Chemistry, Vol. 17, Iss. 8, 2010-03 ,pp. : 750-758

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Anti-HIV-1 Activity of a Novel Series of Aminoimidazole Analogs

Letters in Drug Design & Discovery, Vol. 7, Iss. 5, 2010-06 ,pp. : 318-323

Bentham Science Publishers

Access to resources Recommend Favorite